Trade receivables increased 37.0%
Trade receivables changed +37.0% from the comparable as-filed period.
$10,344→$14,1723 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →AMST financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
R&D / revenue moved 15880 bp higher
R&D / revenue changed +15880 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
109.11%→267.91%2 prior comparisons
Stock-based compensation increased 21.2%
Stock-based compensation changed +21.2% from the comparable as-filed period.
$72,252→$87,5823 prior comparisons
Operating cash-flow margin moved 22344 bp lower
Operating cash-flow margin changed -22344 basis points from the comparable as-filed period.
-440.91%→-664.35%3 prior comparisons
Cash & equivalents decreased 6.9%
Cash & equivalents changed -6.9% from the comparable as-filed period.
$1.8M→$1.7M3 prior comparisons
Current liabilities increased 10.4%
Current liabilities changed +10.4% from the comparable as-filed period.
$427,637→$472,3203 prior comparisons
Total assets decreased 6.0%
Total assets changed -6.0% from the comparable as-filed period.
$2.6M→$2.4M3 prior comparisons
Working capital decreased 7.1%
Working capital changed -7.1% from the comparable as-filed period.
$1.5M→$1.4M3 prior comparisons
Current assets decreased 3.2%
Current assets changed -3.2% from the comparable as-filed period.
$1.9M→$1.8M3 prior comparisons
Working capital / assets moved 65 bp lower
Working capital / assets changed -65 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
56.93%→56.29%3 prior comparisons
Current ratio decreased 12.3%
Current ratio changed -12.3% from the comparable as-filed period.
4.46→3.913 prior comparisons
Research & development decreased 22.0%
Research & development changed -22.0% from the comparable as-filed period.
$172,098→$134,1921 prior comparisons
Current ratio decreased 70.9%
Current ratio changed -70.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
14.88→4.332 prior comparisons
Working capital / assets moved 3452 bp lower
Working capital / assets changed -3452 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
76.87%→42.35%2 prior comparisons
Operating cash-flow margin moved 166724 bp higher
Operating cash-flow margin changed +166724 basis points from the comparable as-filed period.
-2206.23%→-539.00%1 prior comparisons
Receivables / revenue moved 830 bp higher
Receivables / revenue changed +830 basis points from the comparable as-filed period.
14.47%→22.77%1 prior comparisons
R&D / revenue moved 39973 bp lower
R&D / revenue changed -39973 basis points from the comparable as-filed period.
560.76%→161.03%0 prior comparisons
Current liabilities decreased 9.9%
Current liabilities changed -9.9% from the comparable as-filed period.
$210,954→$189,9822 prior comparisons
Operating income increased 0.5%
Operating income changed +0.5% from the comparable as-filed period.
-$687,722→-$684,0721 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.